FLR
53
5
EFX
47
4
CHD
37
-2
IRM
54
5
UHS
58
2
FRT
55
2
QCOM
60
3
L
43
-2
AMAT
66
6
HP
14
-4
LUV
58
4
UAL
53
3
BLK
58
3
AAL
27
6
ZBH
47
2
PCG
56
5
APD
44
7
EQR
30
-3
NTAP
67
2
BDX
32
2
FLR
53
5
EFX
47
4
CHD
37
-2
IRM
54
5
UHS
58
2
FRT
55
2
QCOM
60
3
L
43
-2
AMAT
66
6
HP
14
-4
LUV
58
4
UAL
53
3
BLK
58
3
AAL
27
6
ZBH
47
2
PCG
56
5
APD
44
7
EQR
30
-3
NTAP
67
2
BDX
32
2
Financhill
Back

abrdn Life Sciences Investors Stock Predictions

How to hack a $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
50

HQL
abrdn Life Sciences Investors

Last Price:
$12.79
Seasonality Move:
2.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Notable investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa

abrdn Life Sciences Investors Stock Forecast

  • Over the next 52 weeks, abrdn Life Sciences Investors has on average historically risen by 4.1% based on the past 31 years of stock performance.
  • abrdn Life Sciences Investors has risen higher in 15 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.39%
  • Is abrdn Life Sciences Investors Stock Undervalued?
    The current abrdn Life Sciences Investors [HQL] share price is $12.79. The Score for HQL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • HQL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will abrdn Life Sciences Investors Stock Go Up Next Year?

  • Over the next 52 weeks, abrdn Life Sciences Investors has on average historically risen by 4.1% based on the past 31 years of stock performance.

abrdn Life Sciences Investors Stock Rating

Sell
50
abrdn Life Sciences Investors (HQL) is a Sell

Is abrdn Life Sciences Investors overpriced?

  • abrdn Life Sciences Investors has risen higher in 15 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.39%

abrdn Life Sciences Investors Stock Price History

Is HQL stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HQL is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSE
Country:
United States
Industry:
Sector:
Type:
stock
Website:
abrdnhql.com

52-Week Data

52-Week High:
15.90
52-Week Low:
10.55

Prediction Charts

Market Cap:
0
Price in USD:
12.79
Volume:
90.5K
Beta:
0.96

Technical Analysis

SMA50:
12.41
SMA100:
12.80
SMA200:
13.61
52-Wk Change:
-9.68%

Stock Predictions

  • Is abrdn Life Sciences Investors stock public?
    Yes, abrdn Life Sciences Investors is a publicly traded company.
  • What is the abrdn Life Sciences Investors stock quote today?
    The abrdn Life Sciences Investors stock price is 12.79 USD today.
  • How to buy abrdn Life Sciences Investors stock online?
    You can buy abrdn Life Sciences Investors shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-4 12.61 12.55 12.73 12.55
Jun-5 12.57 12.53 12.67 12.49
Jun-6 12.65 12.81 12.83 12.65
Jun-9 12.75 12.80 12.91 12.75
Jun-10 12.86 12.94 13.03 12.86
Jun-11 13.04 13.02 13.12 12.93
Jun-12 13.02 12.98 13.05 12.84
Jun-13 12.81 12.85 12.95 12.77
Jun-16 12.96 12.83 13.00 12.70
Jun-17 12.82 12.60 12.82 12.58
Jun-18 12.66 12.61 12.72 12.55
Jun-20 12.74 12.58 12.74 12.50
Jun-23 12.60 12.47 12.62 12.34
Jun-24 12.58 12.79 12.80 12.49

abrdn Life Sciences Investors Earnings

Data Unavailable

abrdn Life Sciences Investors Forecast Revenue Growth

Data Unavailable

* abrdn Life Sciences Investors stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.